GlassScriptPhysician profile
Mankanwal S Sachdev
NPI 1356307839
$71,416.22
in general payments reported to CMS, 2019-2025
46 companies · $13K in 2025
The $13K reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,296 · 2020: $5,619 · 2021: $1,837 · 2022: $5,477 · 2023: $25K · 2024: $11K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Consulting Fee: $16K · Food and Beverage: $5,968 · Travel and Lodging: $4,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,750.00 |
| Consulting Fee | $15,978.50 |
| Food and Beverage | $5,968.39 |
| Travel and Lodging | $4,491.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $39,934.89 | 2019-2025 | General - Therapies, Exalt Model D, Orise |
| Micro-Tech Endoscopy USA, INC. | $6,622.31 | 2019-2023 | Eus Needles, Eyemax |
| Medtronic, INC. | $4,154.53 | 2021-2025 | Gi Genius, Prodigi, Endoflip |
| Genzyme Corporation | $4,091.27 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $3,427.52 | 2024 | Voquezna |
| Olympus Medical Systems Corporation | $2,612.50 | 2025 | Evis Exera III Duodenovideoscope, Disposable Hot Biopsy Forceps |
| Olympus Corporation of The Americas | $2,060.43 | 2019 | |
| Creo Medical INC. | $1,088.84 | 2021-2023 | Speedboat |
| Apollo Endosurgery US INC | $974.68 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Conmed Corporation | $840.00 | 2024 | Airseal |
| Gi Supply, INC. | $700.00 | 2020 | |
| Olympus America INC. | $616.55 | 2019-2023 | Endoclot Phs |
| Ambu INC. | $509.29 | 2020-2022 | |
| Madrigal Pharmaceuticals | $430.11 | 2024-2025 | Rezdiffra |
| Endogastric Solutions, INC | $404.26 | 2019-2024 | Esophyx |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mankanwal Sachdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.